Table 1. Patient and tumor characteristics.
| Characteristics | N = 43 |
|---|---|
| Age (year), median (range) | 71 (48–85) |
| Sex, male/female | 30/13 |
| Performance status, 0/1/2 | 22/19/2 |
| Child-Pugh classification, A/B | 40/3 |
| AJCC, I/II/III | 24/10/9 |
| Etiology of liver disease | |
| HBV | 23 (53.4%) |
| HCV | 15 (34.9%) |
| Alcoholic | 2 (4.7%) |
| Liver cirrhosis | 42 (97.7%) |
| Underlying disease | |
| Hypertension | 21 (48.8%) |
| Diabetes mellitus | 12 (27.9%) |
| Coronary artery disease | 7 (16.3%) |
| Alfa fetoprotein, ng/mL | |
| Median | 13.2 |
| Range | 2.1–143121.3 |
| Tumor size in maximum diameter | |
| Median (range), cm | 3.1 (1.1–17.1) |
| < 5 cm | 31 (72.1%) |
| ≥ 5 cm | 12 (27.9%) |
| Number of tumors | |
| Single | 33 (76.7%) |
| Multiple | 10 (23.3%) |
| Portal vein thrombosis | |
| Present | 8 (18.6%) |
| Absent | 35 (81.4%) |
| Hepatic vein thrombosis | |
| Present | 3 (7.0%) |
| Absent | 40 (93.0%) |
| Bile duct dilatation | |
| Present | 6 (14.0%) |
| Absent | 37 (86.0%) |
AJCC: American Joint Committee on Cancer 8th edition; HBV: hepatitis B virus; HCV: hepatitis C virus.